Skip to content

Feasibility of a Technology-Based Treatment Support System

Feasibility of a Technology-Based Treatment Support System

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03121937
Enrollment
11
Registered
2017-04-20
Start date
2017-08-01
Completion date
2018-06-30
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Depressive Disorder, Major

Brief summary

This study aims to evaluate a technology-based treatment support system for patients undergoing the treatment of depression. The investigators will explore the usefulness of the technology-based treatment support system as an adjunct to psychotherapy for depression.

Detailed description

This study aims to evaluate a technology-based treatment support system mConnect for patients undergoing the treatment of depression. This system will be evaluated by conducting a randomized controlled trial where patients will either receive the mConnect mobile app or treatment as usual.

Interventions

BEHAVIORALMobile App

The mobile app mConnect is an app designed to facilitate psychotherapy for depression and includes mood tracking, goal setting, and communication

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * English-speaking * Currently enrolled in outpatient treatment * Current diagnosis of major depressive disorder * Ownership of a smartphone device compatible with the mobile app

Exclusion criteria

* visual, hearing, voice, or motor impairment that would prevent completion of the study procedures or use of mobile phone * diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder, or other diagnosis for which participation in this trial is inappropriate, severe suicidality (has ideation, plan, and intent). * having completed more than 3 sessions of psychotherapy with current therapist

Design outcomes

Primary

MeasureTime frameDescription
Retention8 weeksNumber of completed sessions
Adherence8 weeksThe use of the mobile app. This data will be collected passively by the mobile app sending the following information to the secure server: the date and time the mobile app is launched, the date and time any information is entered into the mobile app, the content of any information entered into the mobile app, the date and time any lessons within the mobile app are read by the participant.
Satisfaction8 weeksParticipant satisfaction with the mobile app will be assessed with a patient version of the Mobile App Rating Scale (MARS) that addresses engagement, functionality, aesthestics, information quality, and one subjective rating of the app as a whole.

Secondary

MeasureTime frameDescription
Depression8 weeksDepression as measured by the PHQ-9

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026